Recent Headlines
Within Medical Laboratories & Research

Investing in Health Pays Off - Nicaragua

The Roberto Clemente Health Clinic’s Annual Health Care Fair on February 4 was a success, with numbers far surpassing expectations. Around 1,200 residents, who live in the remote communities of southwest Nicaragua, received free health care in Limon 1, Tola, Rivas. Adults patiently waited to... - March 30, 2012 - The Roberto Clemente Health Clinic

Hometown Urgent Care Opens in Latonia Kentucky

Hometown Urgent Care and WorkCare Center will open in the Latonia Center in front of Kroger. - March 29, 2012 - Hometown Urgent Care

Rosa to Present Systems Pharmacology Workshop at 3rd Annual World PK/PD Summit

Rosa Workshop Presents the MQM Quality Standard for Mechanistic Modeling - March 26, 2012 - Rosa & Co LLC

ImpactRx Acquires AlphaDetail

Addition of AlphaDetail’s global custom market research expertise enhances and expands company’s solutions offerings. - March 25, 2012 - ImpactRx, Inc

Rosa to Present at 2012 Keystone Symposia: Advances in Islet Biology

Modeling analysis enables development of biomarkers for beta cell mass. - March 24, 2012 - Rosa & Co LLC

ALS Therapy Development Institute Announces Eighth Annual "The Cure Is Coming" 5k and Awareness Walk

Participants walk, ride or race to raise money and awareness to end ALS (Lou Gehrig's disease) - March 21, 2012 - ALS Therapy Development Institute

Detroit R&D and ALPCO Diagnostics Sign Distribution Agreement

ALPCO Diagnostics and Detroit R&D agree to a distribution partnership in North America. - March 20, 2012 - ALPCO

Colorado BioScience Association Commends PhRMA and We Work For Health for Showcasing the Critical Importance of Clinical Trials to Chronic Disease Sufferers in the State

Members of Colorado BioScience Association (CBSA) today joined with colleagues from both the public and private sectors, including Colorado Governor John Hickenlooper, at a State Capitol News Conference to applaud the release of PhRMA's new report: “Research in Your Backyard.” Colorado's biopharmaceutical industry assists sufferers of chronic disease and includes approximately 300 companies employing over 5,410 with average salaries of $93,000. - March 19, 2012 - Colorado BioScience Association

Fitzsimons Redevelopment Authority Names New President & CEO

Following an extensive national search, Fitzsimons Redevelopment Authority (FRA) has named Steve VanNurden as its new President & CEO. VanNurden, a seasoned leader in the life science/bioscience space, comes to FRA from Mayo Clinic in Rochester, Minnesota. - March 16, 2012 - Fitzsimons Redevelopment Authority

FEECO Australia Celebrates One Year

FEECO International’s Australia branch is celebrating its one-year anniversary this March. - March 16, 2012 - Feeco International Australia

Dr. Joga Gobburu to Discuss the Impact of Pharmacometrics on Drug Approvals in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

Dr. Gobburu will present “Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions” March 20, 2012. - March 16, 2012 - Rosa & Co LLC

Rosa PK/PD Collaboration with Pfizer to be Presented at ASCPT 2012

PK/PD analyses used to support the rationale for therapeutic strategies targeting myostatin pathway. - March 10, 2012 - Rosa & Co LLC

ADHD - Making Strides with the International Brain Research Foundation

It is not uncommon for students to become distracted and bored in school especially when the subject or lecture is not of high interest. However, when these behaviors significantly interfere with academic performance or result in conduct problems, parents and teachers become frustrated. Often such... - March 09, 2012 - International Brain Research Foundation

RRI Group/Akesis Has Been Part of 60 Dermatology Development Programs

Let RRI Group/Akesis put its Clinical Experience to work for you. RRI Group/Akesis' passion is helping Companies...Grow. - March 08, 2012 - RRI Group/Akesis

IonSense Introduces the DART®-OS Source. Expands Its OpenSpot Mass Spectrometry™ Product Line

OpenSpot® Sample Cards Facilitate Simpler Analysis, Eliminating Most Consumables and Solvents, Reducing Lab Waste. Exhibited at Pittcon 2012. Booth #2609. - March 06, 2012 - IonSense, Inc.

DAVA Oncology, LP- Alexander E. Denes, M.D., F.A.C.P. Joins DAVA Oncology as Medical Director

DAVA Oncology, LP is pleased to announce the addition of Alex Denes, MD as a member of the medical oncology support staff. Dr. Denes is from Washington University School of Medicine, where he currently serves as Associate Professor of Medicine. Dr. Denes has an extensive background as a clinician... - March 03, 2012 - Dava Oncology, LP

Rosa Announces Publication of Its PhysioPD™ Model Qualification Method and Series of Educational Events

Series of Seminars and Workshops to be held in 2012 across the US and in Europe. - March 01, 2012 - Rosa & Co LLC

Mitegen Announces Continued Expansion of Product Lines and Offerings for Crystallographers

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, recently announced numerous expansions to both their patented product portfolio and to their line of distributed products. - February 25, 2012 - MiTeGen, LLC

Mitegen Announces Distribution Agreement with Mexico Diffractia S. de R.L.de C.V.

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed a distribution agreement with Mexico Diffractia S. de R.L.de C.V. of... - February 24, 2012 - MiTeGen, LLC

OsoBio Appoints Marian Meyer Director of Labs

Meyer manages the company’s chemistry and microbiology labs, which are responsible for such quality-control services as materials testing and release, environmental monitoring and analytical methods compliance. - February 23, 2012 - OSO BioPharmaceuticals Manufacturing, LLC

FDA Clears ASI’s GenASIs Advanced Imaging for HER-2/neu Analysis

ASI’s GenASIs automated scanning and image analysis system for detection and quantifying chromosome 17 and the HER-2/neu gene has been cleared by the United States Food and Drug Administration (FDA) for marketing in the US. - February 22, 2012 - Applied Spectral Imaging

Biomedica Immunoassays Appoints ALPCO Diagnostics as Its Exclusive Distributor in Canada

ALPCO Diagnostics was recently appointed as Biomedica Immunoassays' exclusive distributor in Canada. - February 15, 2012 - ALPCO

Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing

Boyer has been responsible for guiding business strategies and creating new growth opportunities at OsoBio since 2008 - February 15, 2012 - OSO BioPharmaceuticals Manufacturing, LLC

SFL’s Managing Director to Speak at Healthcare Businesswomen’s Association Event

SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, will be speaking at the upcoming Healthcare Businesswomen’s Association European meeting entitled “The Role of Regulatory Affairs in Successful Development and Launch of Healthcare Products” to be held in Basel, Switzerland. - February 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd

Biopontis Alliance Fund and Rosa Announce Strategic Relationship for Early Stage Drug Development

Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity. - February 07, 2012 - Rosa & Co LLC

Dr. Hartmut Derendorf to Discuss PK/PD-based Drug Development in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

Dr. Derendorf, will present “PK/PD-based Development of Anti-infective Agents” February 13, 2012. - February 06, 2012 - Rosa & Co LLC

Rosa to Present at 2012 Keystone Symposia: Cancer and Metabolism

Modeling analysis enables understanding efficacy of large numbers of potential drug combinations. - February 03, 2012 - Rosa & Co LLC

Mitutoyo Introduces World’s First 0.1µm Micrometer

Mitutoyo America Corporation introduces the first micrometer to offer 0.1µm resolution measurement. The High-Accuracy Digimatic® Digital Micrometer is available in a convenient, hand-held tool. - February 02, 2012 - Mitutoyo America Corporation

Advanced Cancer Therapeutics Chief Scientific Officer to Present Preclinical Data on Glycolysis Inhibitors at World Cancer Metabolism Summit

Advanced Cancer Therapeutics, LLC (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that Dr. Gilles Tapolsky, ACT’s Chief Scientific Officer, has been selected to present at the World Cancer Metabolism Summit to be held February 1 – February 2, 2012 in Washington, D.C. - February 01, 2012 - Advanced Cancer Therapeutics

FDA Clears ASI’s GenASIs Advanced Imaging for UroVysion Analysis

GenASIs Scan & Analysis cleared for FISH Detection and Analysis of chromosomal abnormalities in urine specimens. - February 01, 2012 - Applied Spectral Imaging

Roberto Clemente Health Clinic to Host Health Care Fair

Hundreds of residents who live in the remote communities of southwest Nicaragua will receive free healthcare at the Roberto Clemente Health Clinic’s Annual Health Care Fair from 9 a.m. to 2 p.m. on Saturday, February 4, in Limon 1 Tola, Rivas, Nicaragua. A team of more than 30 medical... - January 31, 2012 - The Roberto Clemente Health Clinic

Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics

Industry Presenters Will Focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development - January 30, 2012 - Rosa & Co LLC

Colorado’s Bioscience Industry Leaders and Legislators Focus on 2012 Initiatives at Annual "BioScience Day at the Capitol"

Colorado BioScience Association (CBSA) is hosting its fourth annual "BioScience Day at the Capitol" on February 2. The CBSA is building upon one of its most successful years in its history, making impressive strides in the areas of industry advocacy, programming, marketing communications, membership and education. - January 30, 2012 - Colorado BioScience Association

Clinical Trials GPS Shares 2011 Q4 Findings; Almost 40% of Trials Aimed at Seniors, Less Than 17% Funded by the Government

Internal data shows a trend towards female participants, a surprisingly low volume of smokers, majority are willing to stay overnight, and an average age of 42. - January 27, 2012 - Clinical Trials Institute

Pfizer and Rosa to Present at 2012 Keystone Symposia: Pathogenesis of Diabetes

Insulin degradation and the mechanisms controlling it have significant impact on glucose homeostasis and diabetes. - January 26, 2012 - Rosa & Co LLC

Clinical Financial Services (CFS) Expands Internationally with Office in Edinburgh, Scotland

Clinical Financial Services, LLC (CFS), a specialty service provider focused on the business and financial management activities for clinical trials, has expanded its global presence by opening a new office in Edinburgh, Scotland. April Mulroney, CA, CPA, having most recently served as Vice... - January 26, 2012 - Clinical Financial Services

Clinical Trials GPS Highlights New Diabetes Trials; Aims to Help the Over 25 Million Individuals in U.S. Affected by Diabetes

25.8 million children and adults in the United States - 8.3% of the population - have diabetes. This equates to $116 billion in direct medical costs, and another $58 billion in indirect costs. - January 25, 2012 - Clinical Trials Institute

Health IT Startup TrialX Wins NCI’s Developer Challenge for Cancer App

TrialX, an NYC based health IT company was declared a winner of a developer challenge organized by the National Cancer Institute for its application, Ask Dory. Ask Dory helps cancer patients find and connect with clinical trials near them effortlessly. - January 25, 2012 - Applied Informatics

Rosa’s Toufigh Gordi to Present at 2nd Annual Pediatric Pharmacology Conference 2012

Integration of PK/PD and mechanistic physiological models improves drug development in infants. - January 24, 2012 - Rosa & Co LLC

New, Interactive Social Media Fundraising Campaign, Arrest ALS, Launched

Innovative fundraising concept leverages social media to raise money and awareness to end ALS. - January 22, 2012 - ALS Therapy Development Institute

BioRegenerative Sciences, Inc. Signs Memorandum of Understanding with Nurture Earth Pvt. Ltd. to Form Stem Cell Joint Venture in India

BioRegenerative Sciences, Inc. of San Diego, CA signs MOU with Nurture Earth, Pvt., Ltd. of India to form joint venture called BioRegenerative Sciences India (BRS India). The new joint venture, BRS India will produce, test, register, and market and sell BRS' stem cell-based therapeutic products in the Asian markets. - January 20, 2012 - BioRegenerative Sciences, Inc.

Life Vessel of the Prairie Announces Grand Opening in Wichita, Kansas

Life Vessel of the Prairie, houses the Life Vessel®, a patented, 510K FDA cleared non-invasive technology and technique by which frequency, vibration, sound and light waves are non-invasively applied to the human body in a resonance chamber, resulting in the body being able to perform its innate natural ability to heal itself. - January 17, 2012 - Hansa Center for Optimum Health

SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis

SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning). - January 12, 2012 - SignaBlok, Inc.

KDL Pathology Receives College of American Pathologists Accreditation

KDL Pathology | Knoxville Dermatopathology Lab announced today that its CLIA-registered laboratory has been accredited by the College of American Pathologists (CAP) following a recent onsite inspection by the Accreditation Committee of CAP. The CAP Accreditation Program is generally recognized as... - January 11, 2012 - KDL Pathology

Applied Spectral Imaging Announces the Launch of the GenASIs Automated Imaging Platforms for Genetic and Pathology Analysis

The GenASIs advanced cytogenetic and pathology platforms are the foundation of ASI’s new offering. With its superior imaging and analysis capabilities, ASI provides state of the art diagnostic aids, offering cytogeneticists and pathologists accurate genetic and pathology analysis. - December 24, 2011 - Applied Spectral Imaging

TTC Study Points to Increasing Clinical Trial Costs in New Geographies

Cost Per Patient on the Rise in Australia, Eastern Europe, and Latin America - December 23, 2011 - TTC LLC

Fitzsimons Redevelopment Authority Announces Second Phase of Strategic Refocus with $8 Million Expansion to Bioscience Park Center with 37,000-Square-Foot Accelerator

The Fitzsimons Redevelopment Authority (FRA) is expanding its Bioscience Park Center (BPC) by roughly 50% with an $8 million, 37,000-square-foot accelerator structure. The new accelerator space will be leased to existing tenants graduating from the incubator and other companies in the modest growth stage. - December 12, 2011 - Fitzsimons Redevelopment Authority

Recent Headlines Within Medical Laboratories & Research

Recent Headlines
Within Medical Laboratories & Research